Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypersensitivity Reaction

  Free Subscription


Articles published in Acta Derm Venereol

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    November 2021
  1. STAUMONT D, Taieb C, Merhand S, Shourick J, et al
    The Atopic Dermatitis Control Tool, A High-Performance Tool for Optimal Support.
    Acta Derm Venereol. 2021 Nov 29. doi: 10.2340.
    PubMed     Abstract available


  2. NYMAN GSA, Gimenez-Arnau AM, Grigaitiene J, Malinauskiene L, et al
    Patch Testing with Propolis of Different Geographical Origins in a Baseline Series.
    Acta Derm Venereol. 2021;101:adv00591.
    PubMed     Abstract available


    October 2021
  3. KWIATKOWSKA D, Reich A
    Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis.
    Acta Derm Venereol. 2021;101:adv00583.
    PubMed     Abstract available


  4. NAKAHARA T, Kido-Nakahara M, Onozuka D, Sakai S, et al
    Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study.
    Acta Derm Venereol. 2021 Oct 28. doi: 10.2340.
    PubMed    


  5. TAKEOKA S, Kamata M, Yokoi I, Takehara A, et al
    Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.
    Acta Derm Venereol. 2021;101:adv00581.
    PubMed    


  6. SILVERBERG JI, Simpson EL, Boguniewicz M, De Bruin-Weller MS, et al
    Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
    Acta Derm Venereol. 2021 Oct 7. doi: 10.2340.
    PubMed     Abstract available


    September 2021
  7. WEISS D, Nordhorn I, Tizek L, Werfel T, et al
    Prescription Behaviour and Barriers to Prescription of Biologicals for Treatment of Chronic Inflammatory Skin Diseases in Dermatological Practice in Two German Federal States.
    Acta Derm Venereol. 2021;101:adv00560.
    PubMed     Abstract available


  8. FERRUCCI SM, Tavecchio S, Angileri L, Surace T, et al
    Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2021 Sep 13. doi: 10.2340/00015555-3922.
    PubMed     Abstract available


  9. CHAN TC, Lin YC, Cho YT, Tang CH, et al
    Impact of Atopic Dermatitis on Work and Activity Impairment in Taiwan.
    Acta Derm Venereol. 2021 Sep 7. doi: 10.2340/00015555-3918.
    PubMed     Abstract available


  10. THYSSEN JP, Brenneche AW, Madsen ME, Pedersen MH, et al
    Societal Costs of Moderate-to-severe Atopic Dermatitis Occurring in Adulthood: A Danish Register-based Study.
    Acta Derm Venereol. 2021;101:adv00538.
    PubMed     Abstract available


  11. WALLENGREN J
    Prurigo Simplex or "Itchy Red Bump" Disease: Review and Case Series.
    Acta Derm Venereol. 2021;101:adv00539.
    PubMed     Abstract available


    August 2021
  12. SORIA A, Thenie C, Bienenfeld C, Staumont-Salle D, et al
    General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France.
    Acta Derm Venereol. 2021 Aug 26. doi: 10.2340/00015555-3913.
    PubMed     Abstract available


  13. ARIENS LFM, Bakker DS, Spekhorst LS, van der Schaft J, et al
    Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry.
    Acta Derm Venereol. 2021 Aug 16. doi: 10.2340/00015555-3886.
    PubMed     Abstract available


    July 2021
  14. KREUTER A, Koushk Jalali B, Meinrath J, Oellig F, et al
    Lupus-like skin Eruptions as Indicator of Disease Progression and Poor Outcome in Patients with Haematological Malignancies.
    Acta Derm Venereol. 2021;101:adv00500.
    PubMed    


  15. CABOUT E, Eymere S, Launois R, Seite S, et al
    Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2021 Jul 7. doi: 10.2340/00015555-3873.
    PubMed     Abstract available


    May 2021
  16. OSADA SI, Sato T
    Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Caused by Lenalidomide: Case Report and Review of the Literature.
    Acta Derm Venereol. 2021;101:adv00468.
    PubMed    


  17. DELEURAN M, Marcoux D, De Bruin-Weller MS, Irvine AD, et al
    Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use.
    Acta Derm Venereol. 2021 May 27. doi: 10.2340/00015555-3848.
    PubMed    


  18. SAKATA S, Ishiuji Y, Katsuta M, Kharma B, et al
    Role of Eosinophil Relative Count and Neutrophil-to-Lymphocyte Ratio in the Assessment of Severity of Atopic Dermatitis.
    Acta Derm Venereol. 2021 May 27. doi: 10.2340/00015555-3838.
    PubMed     Abstract available


  19. KATSUTA M, Ishiuji Y, Matsuzaki H, Yasuda KI, et al
    Transient Increase in Circulating Basophils and Eosinophils in Dupilumab-associated Conjunctivitis in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2021 May 27. doi: 10.2340/00015555-3842.
    PubMed    


  20. BOUAZZI D, Bygum A, Skov L, Lindskov Sachs M, et al
    Establishment of a Nationwide Patient Database for Clinical Trial Recruitment in Dermatology: Concept and Patient Characteristics.
    Acta Derm Venereol. 2021;101:adv00461.
    PubMed    


  21. BRIX ATH, Boysen HB, Weller K, Caballero T, et al
    Patient-reported Outcome Measures for Angioedema: A Literature Review.
    Acta Derm Venereol. 2021;101:adv00456.
    PubMed     Abstract available


    April 2021
  22. TOLLENAERE MAX, Litman T, Moebus L, Rodriguez E, et al
    Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro.
    Acta Derm Venereol. 2021;101:adv00447.
    PubMed    


  23. PAUGOY H, Saussine A, Frumholtz L, Battistella M, et al
    Neutrophilic Urticaria with Systemic Inflammation Associated with Immunoglobulin A Myeloma.
    Acta Derm Venereol. 2021;101:adv00442.
    PubMed    


  24. PECK G, Hashim MJ, Shaughnessy C, Muddasani S, et al
    Global Epidemiology of Urticaria: Increasing Burden among Children, Females and Low-income Regions.
    Acta Derm Venereol. 2021;101:adv00433.
    PubMed     Abstract available


  25. LISTED NA
    Abstracts from 11th George Rajka International Symposium on Atopic Dermatitis.
    Acta Derm Venereol. 2021;101.
    PubMed    


  26. BRUZE M, Marmgren V, Antelmi A, Hindsen Stenstrom M, et al
    Contact Allergy to Oxidized Linalool and Oxidized Limonene is Over-represented in Individuals with Photocontact Allergy to Ketoprofen.
    Acta Derm Venereol. 2021 Apr 13. doi: 10.2340/00015555-3799.
    PubMed     Abstract available


  27. RIOS-VINUELA E, Bernia E, Toledo-Pastrana T, Requena C, et al
    Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance Revisited.
    Acta Derm Venereol. 2021;101:adv00429.
    PubMed    


    March 2021
  28. PESQUE D, Sanchez-Gonzalez B, Gallardo F, Segura S, et al
    Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?
    Acta Derm Venereol. 2021;101:adv00418.
    PubMed    


    February 2021
  29. KAISHO J, Honda T, Dainichi T, Kabashima K, et al
    A Case of Atopic Dermatitis with High Serum Levels of Anti-BP180 Antibody and Dyshidrosiform Blisters Limited to the Palms and Soles.
    Acta Derm Venereol. 2021 Feb 19. doi: 10.2340/00015555-3773.
    PubMed    


  30. ILVES L, Ottas A, Kaldvee B, Abram K, et al
    Metabolomic Analysis of Skin Biopsies from Patients with Atopic Dermatitis Reveals Hallmarks of Inflammation, Disrupted Barrier Function and Oxidative Stress.
    Acta Derm Venereol. 2021 Feb 15. doi: 10.2340/00015555-3766.
    PubMed     Abstract available


    January 2021
  31. DE BRUIN-WELLER M, Biedermann T, Bissonnette R, Deleuran M, et al
    Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies.
    Acta Derm Venereol. 2021 Jan 25. doi: 10.2340/00015555-3751.
    PubMed     Abstract available


  32. LEE H, Li T, Wisell J, Schowinsky J, et al
    Avapritinib for Cutaneous Mastocytosis.
    Acta Derm Venereol. 2021;101:adv00362.
    PubMed    


    December 2020
  33. ANTTI A, Salava A, Perala M, Pelkonen AS, et al
    Are Infants and Toddlers with Moderate-to-severe Atopic Dermatitis Undertreated? Experiences of a Finnish Tertiary Care Hospital.
    Acta Derm Venereol. 2020 Dec 29. doi: 10.2340/00015555-3739.
    PubMed    


  34. FREY S, Kendziora B, Holch JW, Lindner L, et al
    Immune Thrombocytopaenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab.
    Acta Derm Venereol. 2020 Dec 22. doi: 10.2340/00015555-3734.
    PubMed    


    November 2020
  35. LI X, Wu X, Elston DM, Zhang J, et al
    Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib.
    Acta Derm Venereol. 2020 Nov 16. doi: 10.2340/00015555-3693.
    PubMed    


    October 2020
  36. RUKWIED R, Schnakenberg M, Solinkski HJ, Schmelz M, et al
    Transcutaneous Slowly Depolarizing Currents Elicit Pruritus in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2020 Oct 7. doi: 10.2340/00015555-3658.
    PubMed     Abstract available


  37. JAWOREK A, Szafraniec K, Jaworek M, Matusiak L, et al
    Itch Relief in Atopic Dermatitis: Comparison of Narrowband Ultraviolet B Radiation and Cyclosporine Treatment.
    Acta Derm Venereol. 2020 Oct 6. doi: 10.2340/00015555-3652.
    PubMed    


  38. EZZEDINE K, Shourick J, Merhand S, Sampogna F, et al
    Impact of Atopic Dermatitis in Adolescents and their Parents: A French Study.
    Acta Derm Venereol. 2020 Oct 6. doi: 10.2340/00015555-3653.
    PubMed     Abstract available


    May 2020
  39. TRAGER MH, de Clippele D, Ram-Wolff C, de Masson A, et al
    Mogamulizumab-induced Mucocutaneous Lichenoid Reaction: A Case Report and Short Review.
    Acta Derm Venereol. 2020;100:adv00158.
    PubMed     Abstract available


  40. CZARNY J, Zuk M, Zawrocki A, Plata-Nazar K, et al
    New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood.
    Acta Derm Venereol. 2020;100:adv00149.
    PubMed     Abstract available


  41. LOTTS T, Kabrodt K, Hummel J, Binder D, et al
    Isatis tinctoria L.-derived Petroleum Ether Extract Mediates Anti-inflammatory Effects via Inhibition of Interleukin-6, Interleukin-33 and Mast Cell Degranulation.
    Acta Derm Venereol. 2020;100:adv00131.
    PubMed     Abstract available


    March 2020
  42. CHELLI C, Loget J, Vanhaecke C, Durlach A, et al
    Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis.
    Acta Derm Venereol. 2020;100:adv00077.
    PubMed    


  43. DASCHNER A
    Changing Assessment of Diet in Chronic Spontaneous Urticaria.
    Acta Derm Venereol. 2020;100:adv00076.
    PubMed    


    February 2020
  44. MOCKENHAUPT M
    Bullous Drug Reactions.
    Acta Derm Venereol. 2020;100:adv00057.
    PubMed     Abstract available


  45. SIMONSEN AB, Larsen MH, von Buchwald C, Kofoed K, et al
    A Challenging Case of Subcutaneous and Mucosal Haemorrhage Caused by Urticarial Vasculitis (Urticaria Haemorrhagica Profunda).
    Acta Derm Venereol. 2020;100:adv00052.
    PubMed    


    January 2020
  46. MISERY L, Taieb C, Brenaut E, Huet F, et al
    Sensitive Skin in Children.
    Acta Derm Venereol. 2020;100:adv00039.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: